Differential effects of balloon pulmonary angioplasty on chronic thromboembolic pulmonary disease

Background Decreased diffusing capacity of the lungs for carbon monoxide (DLco) is associated with microvascular damage in chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) is an effective treatment for CTEPH, but the efficacy of BPA in patients with CTEPH with low DLco remains unclear because BPA does not directly address microvascular damage. This study investigates the influence of microvasculopathy on BPA in CTEPH according to DLco.Methods We retrospectively analysed data from patients with inoperable CTEPH who underwent BPA at the University of Tokyo Hospital from July 2011 to August 2023. The patients were classified into two groups based on their preprocedural DLco (normal DLco (ND) and low DLco (LD) groups), with a DLco cut-off value of 80%. We compared the patient characteristics and effectiveness of BPA between the groups.Results Among the 75 patients, 36 were in the LD group. The LD group had a shorter 6-minute walking distance (324 +/- 91 vs 427 +/- 114 m) than the ND group but the mean pulmonary artery pressure (mPAP) was similar (38.9 +/- 7.3 vs 41.1 +/- 9.2 mm Hg) before BPA. BPA improved the haemodynamic status and exercise tolerance in both groups. The LD group exhibited a higher mPAP (25.1 +/- 7.4 vs 21.5 +/- 5.6 mm Hg) and required more sessions of BPA (median 6 vs 4). Based on the analysis of covariance adjusted for baseline values, low DLco significantly correlated with mPAP (s beta=-0.304, 95% CI -7.015 to -1.132, p=0.007) and pulmonary vascular resistance (s beta=-0.324, 95% CI -141.0 to -29.81, p=0.003).Conclusions BPA was associated with an improvement in the haemodynamic status and exercise tolerance in patients with CTEPH even with low DLco. However, low DLco may attenuate the effect of BPA on mPAP and pulmonary vascular resistance and require more treatment sessions.